From single cells to deep phenotypes in cancer

Baxter Laboratory for Stem Cell Biology, Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, California, USA.
Nature Biotechnology (Impact Factor: 41.51). 07/2012; 30(7):639-47. DOI: 10.1038/nbt.2283
Source: PubMed


In recent years, major advances in single-cell measurement systems have included the introduction of high-throughput versions of traditional flow cytometry that are now capable of measuring intracellular network activity, the emergence of isotope labels that can enable the tracking of a greater variety of cell markers and the development of super-resolution microscopy techniques that allow measurement of RNA expression in single living cells. These technologies will facilitate our capacity to catalog and bring order to the inherent diversity present in cancer cell populations. Alongside these developments, new computational approaches that mine deep data sets are facilitating the visualization of the shape of the data and enabling the extraction of meaningful outputs. These applications have the potential to reveal new insights into cancer biology at the intersections of stem cell function, tumor-initiating cells and multilineage tumor development. In the clinic, they may also prove important not only in the development of new diagnostic modalities but also in understanding how the emergence of tumor cell clones harboring different sets of mutations predispose patients to relapse or disease progression.

Download full-text


Available from: Sean C Bendall, Apr 21, 2014
  • Source
    • "In datasets with a low number of dimensions and limited cross-sample technical and biological variability (e.g., clinical laboratories), manual analysis of specific cell populations can produce effective and reproducible results. However, exploratory analysis of a large number of cell populations in a high-dimensional dataset is not feasible [34]. In addition, manual analysis in less controlled settings (e.g., cross-laboratory studies) can increase the overall error rate of the study [35]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Flow cytometry bioinformatics is the application of bioinformatics to flow cytometry data, which involves storing, retrieving, organizing, and analyzing flow cytometry data using extensive computational resources and tools. Flow cytometry bioinformatics requires extensive use of and contributes to the development of techniques from computational statistics and machine learning. Flow cytometry and related methods allow the quantification of multiple independent biomarkers on large numbers of single cells. The rapid growth in the multidimensionality and throughput of flow cytometry data, particularly in the 2000s, has led to the creation of a variety of computational analysis methods, data standards, and public databases for the sharing of results. Computational methods exist to assist in the preprocessing of flow cytometry data, identifying cell populations within it, matching those cell populations across samples, and performing diagnosis and discovery using the results of previous steps. For preprocessing, this includes compensating for spectral overlap, transforming data onto scales conducive to visualization and analysis, assessing data for quality, and normalizing data across samples and experiments. For population identification, tools are available to aid traditional manual identification of populations in two-dimensional scatter plots (gating), to use dimensionality reduction to aid gating, and to find populations automatically in higher dimensional space in a variety of ways. It is also possible to characterize data in more comprehensive ways, such as the density-guided binary space partitioning technique known as probability binning, or by combinatorial gating. Finally, diagnosis using flow cytometry data can be aided by supervised learning techniques, and discovery of new cell types of biological importance by high-throughput statistical methods, as part of pipelines incorporating all of the aforementioned methods.
    Full-text · Article · Dec 2013 · PLoS Computational Biology
  • Source
    • "As one of the key fields that require strong (laser) irradiation in nature, MS detection and imaging techniques, such as matrix assisted laser desorption/ionization (MALDI) MS, can help to visualise the spatial distribution of molecules without purification, extraction, separation, or labelling of bio-samples, which are important in early stage disease diagnosis and forensic applications2122. Despite the substantial progress, the application of MALDI MS towards small molecules is limited because the matrices (normally small organo molecules like α-cyano-4-hydroxycinnamic acid, CHCA) introduce significant background signals during laser ablation in the low molecular range (<1000 Da). "
    [Show abstract] [Hide abstract]
    ABSTRACT: A pulsed laser engineering approach is developed to prepare novel functional graphene paper with graphitic nanospheres homogeneously decorated on the surface and the superior performance of engineered paper is revealed in matrix-free mass spectrometry (MS) detection and imaging. We demonstrate that the stability of graphene paper under intense irradiation can be dramatically increased through a designed laser engineering process by forming densely packed graphitic nanospheres on the paper surface. Moreover, the surface hydrophobicity is enhanced and electric conductivity is improved. The engineered graphene paper can image the invisible micro-patterns of trace amount molecules and increases the detection limit towards diverse molecules by over two orders of magnitude compared to the pristine graphene paper and commercial products in MS analysis.
    Full-text · Article · Mar 2013 · Scientific Reports
  • Source
    • "Also, microarrays and GWAS necessitate well defined patient cohorts and good quality mRNA and DNA samples. Future development will also focus on combining flow cytometry and mass spectrometry (cytometry by time-of-flight; CyTOF) (Bandura et al., 2009; Bendall and Nolan, 2012). A recent study (Newell et al., 2012) used this method to re-examine the functional and phenotypic diversity of human CD8 T lymphocytes, and identified more than 200 functional phenotypes represented by distinct CD8 T cell subsets (Chen and Weng, 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Complex mechanisms underlying the maintenance of fully functional, proliferative, HIV-1-specific T-cell responses involve processes from early T-cell development through to the final stages of T-cell differentiation and antigen recognition. Virus-specific proliferative CD4 and CD8 T-cell responses, important for the control of infection, are observed in some HIV-1 patients during early stages of disease, and are maintained in long-term non-progressing subjects. In the vast majority of HIV-1 patients, full immune functionality is lost when proliferative HIV-1-specific T-cell responses undergo a variable progressive decline throughout the course of chronic infection. This appears irreparable despite administration of potent combination antiretroviral therapy, which to date is non-curative, necessitating life-long administration and the development of effective, novel, therapeutic interventions. While a sterilizing cure, involving clearance of virus from the host, remains a primary aim, a "functional cure" may be a more feasible goal with considerable impact on worldwide HIV-1 infection. Such an approach would enable long-term co-existence of host and virus in the absence of toxic and costly drugs. Effective immune homeostasis coupled with a balanced response appropriately targeting conserved viral antigens, in a manner that avoids hyperactivation and exhaustion, may prove to be the strongest correlate of durable viral control. This review describes novel concepts underlying full immune functionality in the context of HIV-1 infection, which may be utilized in future strategies designed to improve upon existing therapy. The aim will be to induce long-term non-progressor or elite controller status in every infected host, through immune-mediated control of viremia and reduction of viral reservoirs, leading to lower HIV-1 transmission rates.
    Full-text · Article · Mar 2013 · Frontiers in Immunology
Show more

We use cookies to give you the best possible experience on ResearchGate. Read our cookies policy to learn more.